Internal Medicine, Endocrinology, Diabetes, & Metabolism · Munster, IN
NPI
1063407872
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
761 45th St Ste 110
Munster, IN, 46321
Phone (219) 922-3020
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,421 services
Medicare patients, 2024
538
Average age 73
Drug cost, 2024
$2.7M
5,851 prescriptions
Company payments, 2025
$46.92
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hesham M Bazaraa was code 99214 (office e&m - established), 684 times for 449 patients. In total Hesham M Bazaraa billed 1,421 services in 20 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 684 | 449 | $80.32 | $55K |
| 99215 Office E&M - Established | Office | 185 | 147 | $122.09 | $23K |
| 95251 Test - Miscellaneous | Office | 92 | 56 | $25.43 | $2,340 |
| 83036 Blood Count | Office | 91 | 71 | $9.52 | $866 |
| 96372 Injection Administration | Office | 82 | 14 | $9.77 | $801 |
| 82962 Clinical Chemistry | Office | 75 | 59 | $3.21 | $241 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 65 | 12 | $0.92 | $60.06 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 49 | 23 | $38.90 | $1,906 |
| 99443 Telephone Services | Office | 38 | 32 | $62.71 | $2,383 |
| 95249 Test - Miscellaneous | Office | 15 | 11 | $46.66 | $700 |
| 99205 Office E&M - New | Office | 11 | 11 | $134.36 | $1,478 |
By year: 2022 $94K for 1,493 services; 2023 $93K for 1,664 services; 2024 $90K for 1,421 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 91 | 71 | $9.52 | $866 |
| 82962 Clinical Chemistry | 75 | 59 | $3.21 | $241 |
Medicare prescription drug claims, 2024
In 2024, the drug Hesham M Bazaraa prescribed most often to Medicare patients was Levothyroxine Sodium, with 853 prescriptions and refills. In total Hesham M Bazaraa wrote 5,851 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 853 | 2,435 | 236 | $8,664 |
| Ozempic Semaglutide | 511 | 1,062 | 112 | $1.0M |
| Metformin Hcl Er Metformin Hcl | 409 | 1,146 | 118 | $4,745 |
| Metformin Hcl Generic | 324 | 862 | 83 | $2,015 |
| Synthroid Levothyroxine Sodium | 306 | 805 | 85 | $32K |
| Mounjaro Tirzepatide | 252 | 272 | 46 | $284K |
| Atorvastatin Calcium Generic | 235 | 679 | 70 | $2,047 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 177 | 410 | 57 | $30K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 155 | 377 | 61 | $20K |
| Glimepiride Generic | 145 | 432 | 47 | $1,474 |
| Tresiba Flextouch U-200 Insulin Degludec | 129 | 325 | 42 | $217K |
| Trulicity Dulaglutide | 111 | 194 | 23 | $186K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 104 | 242 | 36 | $12K |
| Methimazole Generic | 102 | 289 | 32 | $821 |
| Glipizide Generic | 101 | 277 | 26 | $592 |
Brand drugs: 2,860 claims; generic drugs: 2,478 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hesham M Bazaraa $46.92 ($46.92 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $25.19.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $25.19 |
| Ascensia Diabetes Care Us Inc. | 1 | $21.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.